MU
36
-6
BRK.B
45
2
COP
47
2
CVS
52
-6
CB
55
2
SWK
67
-4
GILD
54
3
CVX
46
8
INTU
56
3
NRG
60
18
HSIC
60
-2
ALLE
39
-2
KLAC
53
-3
WDC
63
13
COST
66
3
IRM
52
2
BBY
42
2
DG
6
-4
EFX
41
-5
WMT
79
3
MU
36
-6
BRK.B
45
2
COP
47
2
CVS
52
-6
CB
55
2
SWK
67
-4
GILD
54
3
CVX
46
8
INTU
56
3
NRG
60
18
HSIC
60
-2
ALLE
39
-2
KLAC
53
-3
WDC
63
13
COST
66
3
IRM
52
2
BBY
42
2
DG
6
-4
EFX
41
-5
WMT
79
3
Financhill
Back

MEI Pharma 10K Form

Sell
46

MEIP
MEI Pharma

Last Price:
2.84
Seasonality Move:
-0.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MEIP News And Ratings

See the #1 stock for the next 7 days that we like better than MEIP

MEIP Financial Statistics

Sales & Book Value

Annual Sales: $65.3M
Cash Flow: $-11.45M
Price / Cash Flow: 0
Annual Sales: $3.73
Price / Book: 0.76

Profitability

EPS (TTM): -6.99000
Net Income (TTM): $-46.6M
Gross Margin: $40.7M
Return on Equity: 0%
Return on Assets: 0%

MEI Pharma Earnings Forecast

Key MEI Pharma Financial Ratios

  • The Gross Profit Margin over the past 20 years for MEIP is 100.01%.
  • The Selling, General & Administrative Expenses for MEIP have been equal to 35.68% of Gross Profit Margin.
  • The Research & Development expenses have been 25.36% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 15 years.

MEI Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MEIP
CUSIP: 55279B
Website: meipharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 1.06
Forward P/E Ratio: 0

MEIP Technical Analysis vs Fundamental Analysis

Sell
46
MEI Pharma (MEIP) is a Sell

Is MEI Pharma a Buy or a Sell?

  • MEI Pharma stock is rated a Sell
    The current MEI Pharma [MEIP] share price is $2.84. The Score for MEIP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.